A Study of Single and Multiple Doses of ALXN1210 in Healthy, Adult Japanese Participants
Status:
Completed
Trial end date:
2017-07-05
Target enrollment:
Participant gender:
Summary
This study evaluated the safety and tolerability of single and multiple doses (400 and 800
milligrams [mg]) of ALXN1210 following intravenous administration to healthy Japanese
participants.